The Regulation of Glucose Transport by Insulin

胰岛素对葡萄糖转运的调节

基本信息

  • 批准号:
    6445826
  • 负责人:
  • 金额:
    $ 4.42万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-02-12 至
  • 项目状态:
    未结题

项目摘要

DESCRIPTION: (Provided By Applicant) Insulin stimulates glucose uptake into muscle and adipose tissue through the translocation of the insulin-responsive glucose transporter type 4 (GLUT4) from an intracellular compartment to the cell surface. Although this translocation event requires the activation of phosphatidylinositol 3-kinase (PI 3-kinase) it is not sufficient, implicating a second signaling pathway. The PI 3-kinase-independent pathway involves the tyrosinc phosphorylation of the proto-oncogene c-cbl through the adaptor protein. cbl-associated protein (CAP). A downstream effector of the CAP/cbl pathway is teratocareinoma 10 (TC 10), a member of the Rho family of GTpases. Clone#38 was discovered as a protein that interacts with the syntaxin 4-interacting protein (synip) in a yeast two-hybrid screening. Synip is a negative regulator of syntaxin 4, the receptor for GLUT4 vesicle docking at the plasma membrane. Interestingly, this novel protein posses a RhoGAP domain that interacts with TC10. In addition, it also possesses a PX and SH3 protein interaction domains that are important for binding of signaling molecules. Thus, our hypothesis is that clone#38 is a scaffolding protein that recruits insulin signaling molecules to the site of GLUT4 vesicle docking. To test this hypothesis, I will first biochemically characterize clone#38 interaction with synip and TC10. Deletional mutants that fail to interact with synip or TC10 will be used in specific aim 2 to evaluate the role of clone#38 in insulin-stimulated glucose uptake and GLUT4 translocation. In specific aim 3, I will search for proteins that bind to the PX and SH3 domains of clone#38. This approach may lead to new insights into the molecular mechanism of insulin action.
说明:(由申请人提供)胰岛素刺激葡萄糖摄取

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOSEPH B HWANG其他文献

JOSEPH B HWANG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOSEPH B HWANG', 18)}}的其他基金

The Regulation of Glucose Transport by Insulin
胰岛素对葡萄糖转运的调节
  • 批准号:
    6698995
  • 财政年份:
    2002
  • 资助金额:
    $ 4.42万
  • 项目类别:
The Regulation of Glucose Transport by Insulin
胰岛素对葡萄糖转运的调节
  • 批准号:
    6622402
  • 财政年份:
    2002
  • 资助金额:
    $ 4.42万
  • 项目类别:

相似海外基金

Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
  • 批准号:
    23K06731
  • 财政年份:
    2023
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
  • 批准号:
    23K06616
  • 财政年份:
    2023
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
  • 批准号:
    10597799
  • 财政年份:
    2023
  • 资助金额:
    $ 4.42万
  • 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
  • 批准号:
    EP/Y024591/1
  • 财政年份:
    2023
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
  • 批准号:
    10672364
  • 财政年份:
    2022
  • 资助金额:
    $ 4.42万
  • 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
  • 批准号:
    10385037
  • 财政年份:
    2022
  • 资助金额:
    $ 4.42万
  • 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
  • 批准号:
    10383462
  • 财政年份:
    2022
  • 资助金额:
    $ 4.42万
  • 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
  • 批准号:
    10483063
  • 财政年份:
    2022
  • 资助金额:
    $ 4.42万
  • 项目类别:
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
  • 批准号:
    10546865
  • 财政年份:
    2022
  • 资助金额:
    $ 4.42万
  • 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
  • 批准号:
    2752732
  • 财政年份:
    2022
  • 资助金额:
    $ 4.42万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了